<DOC>
	<DOCNO>NCT02134366</DOCNO>
	<brief_summary>The purpose study evaluate whether clobazam , brand name Onf® , effective adjunctive monotherapy terminate Epilepsia Partialis Continua ( EPC ) either lorazepam and/or clonazepam .</brief_summary>
	<brief_title>Clobazam Use Epilepsia Partialis Continua - Pilot Study</brief_title>
	<detailed_description>First approve United States 2011 use treat Lennox-Gastaut syndrome , clobazam 1 , 5-benzodiazepine currently approve clinical use United States . In previous clinical trial clobazam show great efficacy produce few side effect individual 's adverse event profile compare traditional 1,4-benzodiazepines diazepam , lorazepam , clonazepam . As benzodiazepine , clobazam find anticonvulsant property , structural difference 1,5-benzodiazepines appear broad spectrum anticonvulsant activity find 1,4-benzodiazepines . In previous report , clobazam see effective ether terminate reduce EPC particular partial status epilepticus .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsia Partialis Continua</mesh_term>
	<mesh_term>Clobazam</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>•≥ 18 yrs age •Diagnosis EPC Neurologist Previous exposure clobazam prior presentation Seizure generalization Patients intubate IV sedation Versed® , Propofol Presedex® . Female subject pregnant and/or breastfeed Subject unstable and/or serious psychiatric illness Subject unstable and/or serious medical illness Subject follow limited condition : A life threaten medical condition Severe sepsis septic shock Severe Renal impairment Severe Hepatic impairment Sleep apnea Narrow angle glaucoma Severe respiratory insufficiency Myasthenia gravis Metastatic cancer Organ failure Severe progressive nervous system disease A clinically significant EKG abnormality would affect and/or affect patient 's participation trial Subject active suicidal ideation Screening Baseline visit Subject history suicidal thought behavior , would indicate positive response question 4 and/or 5 CSSRS . Exclusionary action include limited : Previous intent act suicidal ideation specific plan Previous preparatory act behavior A previous actual attempt , interrupt attempt abort suicide attempt Subject history alcohol and/or substance abuse previous 12 month , subject unable refrain alcohol and/or substance abuse study . Subject admit present illicit drug use positive drug screen Subject currently enrol enrolled clinical trial within past 30 day Subject know allergy component study medication ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Epilepsia Partialis Continua</keyword>
	<keyword>Kojewnikov 's Epilepsy</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Clobazam</keyword>
	<keyword>Focal Motor Epilepsy</keyword>
	<keyword>Partial Motor Seizure</keyword>
</DOC>